Stericycle (SRCL) Cash Flow Statement

Click line-items for a historical chart and %

Net income	189M
Gain on sale of assets
Change in fair value of contingent consideration
Accelerated amortization of term loan financing fees
Stock compensation expense	16.67M
Excess tax benefit of stock options exercised	0
Depreciation	94.08M
Amortization	102.31M
Deferred income taxes
Accounts receivable	-26.83M
Accounts payable	681K
Accrued liabilities	6.14M
Deferred revenues	-1.23M
Other assets and liabilities	18.66M
Net cash provided by operating activities
Payments for acquisitions and international investments, net of cash acquired
Purchase of short-term investments
Proceeds from sale of assets
Capital expenditures	-100.98M
Net cash used in investing activities
Repayment of long-term debt	-68.21M
Borrowings on senior credit facility	1.21B
Repayments on senior credit facility	-1.12B
Payments of deferred consideration
Payments on capital lease obligations	-4.64M
Purchase/ cancellation of treasury stock	-40.81M
Proceeds from other issuance of common stock	35.73M
Excess tax benefit of stock options exercised	0
Net cash provided by/ (used in) financing activities
Effect of exchange rate changes on cash	2.32M
Net decrease in cash and cash equivalents	-15.34M
Cash and cash equivalents at beginning of period	55.63M
Cash and cash equivalents at end of period	40.29M
Net issuance of notes payable for certain acquisitions

Entities mentioned with SRCL

View All Entities